Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05702203

Creative Music Therapy in Newborns With Congenital Heart Disease

Creative Music Therapy in Newborns With Congenital Heart Disease: A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
164 (estimated)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
1 Minute – 28 Days
Healthy volunteers
Not accepted

Summary

In the context of a clinical trial, the investigators will evaluate if parent-infant interaction can be improved by a family integrated, individualised, interactive resource- and needs-oriented music therapy approach in the dyads of infants with congenital heart disease and their parents. This intervention will be compared with the standard of care. Infants allocated to the control group will receive standard care during admission. Standard care includes involvement of a multi-professional team consisting of medical and nursing team, psychologists/psychiatrists, social workers, breastfeeding counsellor, speech therapist, nutritional counsellor and physiotherapists.

Detailed description

Open label single-centre randomised controlled interventional trial. All infants with congenital heart disease (CHD) and age \<28 days admitted to the neonatal and paediatric intensive care unit at the University Children's Hospital in Zurich are eligible. Infants will be allocated 1:1 to creative music therapy (CMT) and standard care using block randomization with stratification by socio-economic score (SES, \<8 vs \>8) and risk of CHD according to the Risk Stratification for Congenital Heart Surgery (RACHS-2). CMT will be conducted 3x/week with a minimum of ten sessions. The primary outcome is mother-infant interaction at age 6 months assessed using a video of a feeding interaction at home, coded in a blinded manner with the Parent-Child Early Relational Assessment.

Conditions

Interventions

TypeNameDescription
OTHERCreative Music TherapyCreative Music Therapy 3x20 minutes per week during admission, at least 10 session during admission, after discharge once every other week until 6 months of age.

Timeline

Start date
2022-11-22
Primary completion
2025-10-21
Completion
2026-10-24
First posted
2023-01-27
Last updated
2023-01-27

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05702203. Inclusion in this directory is not an endorsement.